FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1259513005> ?p ?o ?g. }

• W1259513005 endingPage "257" @default.
• W1259513005 startingPage "248" @default.
• W1259513005 abstract "The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. MK+ AML was associated with higher disease relapse (hazard ratio, 1.98; P < .01), similar transplantation-related mortality (TRM) (hazard ratio, 1.01; P = .90), and worse survival (hazard ratio, 1.67; P < .01) compared with those outcomes for other cytogenetically defined AML. Among patients with MDS, MK+ MDS was associated with higher disease relapse (hazard ratio, 2.39; P < .01), higher TRM (hazard ratio, 1.80; P < .01), and worse survival (HR, 2.02; P < .01). Subset analyses comparing chromosome 7 abnormalities (del7/7q) with or without MK+ demonstrated higher mortality for MK+ disease in for both AML (hazard ratio, 1.72; P < .01) and MDS (hazard ratio, 1.79; P < .01). The strong negative impact of MK+ in myeloid malignancies was observed in all age groups and using either myeloablative or reduced-intensity conditioning regimens. Alternative approaches to mitigate disease relapse in this population are needed." @default.
• W1259513005 created "2016-06-24" @default.
• W1259513005 creator A5000120418 @default.
• W1259513005 creator A5001124933 @default.
• W1259513005 creator A5001697191 @default.
• W1259513005 creator A5003097876 @default.
• W1259513005 creator A5006173110 @default.
• W1259513005 creator A5008376636 @default.
• W1259513005 creator A5008762363 @default.
• W1259513005 creator A5009654984 @default.
• W1259513005 creator A5012489403 @default.
• W1259513005 creator A5012759949 @default.
• W1259513005 creator A5014838335 @default.
• W1259513005 creator A5016014484 @default.
• W1259513005 creator A5017044459 @default.
• W1259513005 creator A5018065917 @default.
• W1259513005 creator A5019979915 @default.
• W1259513005 creator A5020804276 @default.
• W1259513005 creator A5022714308 @default.
• W1259513005 creator A5023700544 @default.
• W1259513005 creator A5034779401 @default.
• W1259513005 creator A5041526386 @default.
• W1259513005 creator A5042915360 @default.
• W1259513005 creator A5042974681 @default.
• W1259513005 creator A5051092535 @default.
• W1259513005 creator A5053410437 @default.
• W1259513005 creator A5058862489 @default.
• W1259513005 creator A5062103615 @default.
• W1259513005 creator A5062116571 @default.
• W1259513005 creator A5062691289 @default.
• W1259513005 creator A5063691844 @default.
• W1259513005 creator A5065085606 @default.
• W1259513005 creator A5067214379 @default.
• W1259513005 creator A5070132319 @default.
• W1259513005 creator A5073620732 @default.
• W1259513005 creator A5074028658 @default.
• W1259513005 creator A5076550283 @default.
• W1259513005 creator A5083504452 @default.
• W1259513005 creator A5085076031 @default.
• W1259513005 creator A5085167557 @default.
• W1259513005 creator A5085360755 @default.
• W1259513005 creator A5086380393 @default.
• W1259513005 creator A5086815330 @default.
• W1259513005 creator A5088486180 @default.
• W1259513005 creator A5088647781 @default.
• W1259513005 creator A5088800804 @default.
• W1259513005 creator A5088962035 @default.
• W1259513005 creator A5091667952 @default.
• W1259513005 date "2016-02-01" @default.
• W1259513005 modified "2023-10-18" @default.
• W1259513005 title "Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies" @default.
• W1259513005 cites W1492609361 @default.
• W1259513005 cites W1534965621 @default.
• W1259513005 cites W187238933 @default.
• W1259513005 cites W1902925323 @default.
• W1259513005 cites W1972047494 @default.
• W1259513005 cites W1978659582 @default.
• W1259513005 cites W1979616872 @default.
• W1259513005 cites W1979650445 @default.
• W1259513005 cites W1984761747 @default.
• W1259513005 cites W1986993506 @default.
• W1259513005 cites W1989506625 @default.
• W1259513005 cites W1990214407 @default.
• W1259513005 cites W1990272282 @default.
• W1259513005 cites W1995726388 @default.
• W1259513005 cites W1996026278 @default.
• W1259513005 cites W2000580405 @default.
• W1259513005 cites W2005292327 @default.
• W1259513005 cites W2019612203 @default.
• W1259513005 cites W2028142301 @default.
• W1259513005 cites W2032699876 @default.
• W1259513005 cites W2041356430 @default.
• W1259513005 cites W2045490767 @default.
• W1259513005 cites W2045532132 @default.
• W1259513005 cites W2048706755 @default.
• W1259513005 cites W2055946535 @default.
• W1259513005 cites W2059210394 @default.
• W1259513005 cites W2062894106 @default.
• W1259513005 cites W2070647577 @default.
• W1259513005 cites W2084267226 @default.
• W1259513005 cites W2092727119 @default.
• W1259513005 cites W2095127408 @default.
• W1259513005 cites W2098355123 @default.
• W1259513005 cites W2108702248 @default.
• W1259513005 cites W2117446917 @default.
• W1259513005 cites W2130675134 @default.
• W1259513005 cites W2139069120 @default.
• W1259513005 cites W2141368628 @default.
• W1259513005 cites W2144395887 @default.
• W1259513005 cites W2148047805 @default.
• W1259513005 cites W2160646954 @default.
• W1259513005 cites W2167765664 @default.
• W1259513005 cites W2169476614 @default.
• W1259513005 cites W4251910573 @default.
• W1259513005 doi "https://doi.org/10.1016/j.bbmt.2015.08.024" @default.
• W1259513005 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4716890" @default.
• W1259513005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26327629" @default.
• W1259513005 hasPublicationYear "2016" @default.

• next